001041407 001__ 1041407
001041407 005__ 20250414120450.0
001041407 0247_ $$2doi$$a10.1186/s42466-024-00361-0
001041407 0247_ $$2datacite_doi$$a10.34734/FZJ-2025-02235
001041407 0247_ $$2pmid$$a39815374
001041407 0247_ $$2WOS$$aWOS:001398048900001
001041407 037__ $$aFZJ-2025-02235
001041407 082__ $$a610
001041407 1001_ $$00000-0002-8980-9337$$aMeißner, Julius Nicolai$$b0$$eCorresponding author
001041407 245__ $$aIncrease of nitrous oxide-induced neurological disorders – a German multicenter experience
001041407 260__ $$a[London]$$bBioMed Central$$c2025
001041407 3367_ $$2DRIVER$$aarticle
001041407 3367_ $$2DataCite$$aOutput Types/Journal article
001041407 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1744210160_31380
001041407 3367_ $$2BibTeX$$aARTICLE
001041407 3367_ $$2ORCID$$aJOURNAL_ARTICLE
001041407 3367_ $$00$$2EndNote$$aJournal Article
001041407 500__ $$aFundingThis research received no specific grant from any funding agency in thepublic, commercial, or not-for-profit sectors.Open Access funding enabled and organized by Projekt DEAL.
001041407 520__ $$aBackgroundNitrous oxide (N₂O), commonly known as laughing gas, is widely recognized for its anesthetic and analgesic effects, and is frequently used in medical contexts. However, its misuse can lead to significant neurological complications, which are often under-recognized in clinical practice. Recent data on such cases in Germany are rare. We here report the spectrum of neurological complications associated with the recreational use of N₂O, as encountered in German neurology centers.MethodsWe retrospectively analyzed of 23 cases presenting with neurological symptoms following N₂O abuse between July 2020 and August 2024 across five neurology departments in Germany. Data were collected on patient demographics, clinical manifestations, diagnostic findings, and treatment approaches.ResultsOver the last four years the number of cases increased. Clinical presentations primarily included neuropathy, found in all patients, along with myelopathy. The most common symptoms were sensory loss, ataxia, and motor deficits.ConclusionOur data suggest that N₂O abuse is on the rise in Germany. Further initiatives are warranted to raise awareness among users, healthcare and professionals.
001041407 536__ $$0G:(DE-HGF)POF4-5251$$a5251 - Multilevel Brain Organization and Variability (POF4-525)$$cPOF4-525$$fPOF IV$$x0
001041407 588__ $$aDataset connected to CrossRef, Journals: juser.fz-juelich.de
001041407 7001_ $$0P:(DE-HGF)0$$aNeuneier, Janina$$b1
001041407 7001_ $$0P:(DE-HGF)0$$aBartzokis, Iason$$b2
001041407 7001_ $$0P:(DE-HGF)0$$aRehm, Mathias$$b3
001041407 7001_ $$0P:(DE-HGF)0$$aAl-Hayali, Ahmad$$b4
001041407 7001_ $$0P:(DE-Juel1)190954$$aMüller, Marcus$$b5$$ufzj
001041407 7001_ $$0P:(DE-HGF)0$$aPaus, Sebastian$$b6
001041407 7001_ $$0P:(DE-HGF)0$$aLimmroth, Volker$$b7
001041407 7001_ $$0P:(DE-Juel1)131720$$aFink, Gereon R.$$b8$$ufzj
001041407 7001_ $$0P:(DE-HGF)0$$aPetzold, Gabor C.$$b9
001041407 7001_ $$0P:(DE-HGF)0$$aNitsch, Louisa$$b10
001041407 773__ $$0PERI:(DE-600)2947493-0$$a10.1186/s42466-024-00361-0$$gVol. 7, no. 1, p. 3$$n1$$p3$$tNeurological research and practice$$v7$$x2524-3489$$y2025
001041407 8564_ $$uhttps://juser.fz-juelich.de/record/1041407/files/PDF.pdf$$yOpenAccess
001041407 909CO $$ooai:juser.fz-juelich.de:1041407$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
001041407 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)190954$$aForschungszentrum Jülich$$b5$$kFZJ
001041407 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131720$$aForschungszentrum Jülich$$b8$$kFZJ
001041407 9131_ $$0G:(DE-HGF)POF4-525$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF4-5251$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vDecoding Brain Organization and Dysfunction$$x0
001041407 9141_ $$y2025
001041407 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-30
001041407 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
001041407 915__ $$0StatID:(DE-HGF)0112$$2StatID$$aWoS$$bEmerging Sources Citation Index$$d2024-12-30
001041407 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2024-04-10T15:42:53Z
001041407 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2024-04-10T15:42:53Z
001041407 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2024-12-30
001041407 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-30
001041407 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
001041407 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2024-04-10T15:42:53Z
001041407 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2024-12-30
001041407 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-30
001041407 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-30
001041407 920__ $$lyes
001041407 9201_ $$0I:(DE-Juel1)INM-3-20090406$$kINM-3$$lKognitive Neurowissenschaften$$x0
001041407 980__ $$ajournal
001041407 980__ $$aVDB
001041407 980__ $$aUNRESTRICTED
001041407 980__ $$aI:(DE-Juel1)INM-3-20090406
001041407 9801_ $$aFullTexts